Author Correction: A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications

• Mani Iyer Prasanth,
• Dhammika Leshan Wannigama,
• Angela Michelle Reiersen,
• Premrutai Thitilertdecha,
• Anchalee Prasansuklab,
• Tewin Tencomnao,
• Sirikalaya Brimson,
• James Michael Brimson

Affiliations

Mani Iyer Prasanth

Natural Products for Neuroprotection and Anti‑Ageing (Neur‑Age Natura) Research Unit, Chulalongkorn University

Dhammika Leshan Wannigama

Department of Infectious Diseases and Infection Control, Yamagata Prefectural Central Hospital

Angela Michelle Reiersen

Department of Psychiatry, School of Medicine, Washington University in St. Louis

Premrutai Thitilertdecha

Siriraj Research Group in Immunobiology and Therapeutic Sciences, Faculty of Medicine Siriraj Hospital, Mahidol University

Anchalee Prasansuklab

Natural Products for Neuroprotection and Anti‑Ageing (Neur‑Age Natura) Research Unit, Chulalongkorn University

Tewin Tencomnao

Natural Products for Neuroprotection and Anti‑Ageing (Neur‑Age Natura) Research Unit, Chulalongkorn University

Sirikalaya Brimson

Department of Clinical Microscopy, Faculty of Allied Health Sciences, Chulalongkorn University

James Michael Brimson

Natural Products for Neuroprotection and Anti‑Ageing (Neur‑Age Natura) Research Unit, Chulalongkorn University